Cervinka, T http://orcid.org/0000-0002-9345-4233
Lynch, C L
Giangregorio, L
Adachi, J D
Papaioannou, A
Thabane, L
Craven, B C
Article History
Received: 16 November 2016
Revised: 29 April 2017
Accepted: 2 May 2017
First Online: 13 June 2017
Competing interests
: LG has received funding from Merck Canada Inc., and is a co-investigator on a project funded by Amgen Inc. JDA reports grants and personal fees from Amgen Inc., grants and personal fees from Eli Lilly, grants and personal fees from Merck Canada Inc., grants from Actavis, personal fees from Agnovos, outside the submitted work. BCC reports consulting fees from the Rick Hansen Institute. The remaining authors declare no conflict of interest.